ZEB1 and cancer: Regarding metastatic bladder cancer, GA directly targeted the key EMT regulator ZEB1 by upregulating miR-205-5p, which decreased ZEB1 protein expression, restored the E-cadherin/N-cadherin ratio, blocked the EMT pathway, and reduced cancer cell invasion and migration.